Search

everythinglearnresearchcommunity

for

Search:↓

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Raspberry ketone may help grow hair and improve skin elasticity.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Mice with more Flightless I protein grew back their claws better after amputation.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Alopecic hair has more irregular structures and chemical changes than normal hair, reducing its strength.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Runx1 helps control the KAP5 gene in human hair follicles.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Removing the Crif1 gene in mouse skin disrupts skin balance and hair growth.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Krtap11-1 is important for hair strength and structure.

A new treatment for hair loss shows promise with fewer side effects.

EAAT4 decreases with age, harming skin function and calcium balance.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

AMPK activation may reduce melanoma risk in red-haired individuals.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

KRTAP28-1 gene can help breed sheep with finer wool.